Related Experiment Video
Updated: Jul 10, 2026
04:04
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
[Interventional oncology for lung tumors].
R-T Hoffmann1, T F Jakobs, A Muacevic
1Institut für klinische Radiologie, Klinikum Grosshadern der Ludwig-Maximilians-Universität München, Marchioninistrasse 15, 81377, München, Deutschland. ralf-thorsten.hoffmann@med.uni-muenchen.de
Der Radiologe
|October 19, 2007
Summary
Radiofrequency ablation (RFA) offers a potentially curative treatment for lung tumors, expanding beyond liver cancer treatment. This minimally invasive therapy is being explored alongside emerging treatments like cyberknife surgery for improved patient outcomes.
Area of Science:
- Oncology
- Interventional Radiology
- Pulmonology
Background:
- Lung tumors and pulmonary metastases are leading causes of cancer death.
- Surgical resection is the current gold standard for potentially curative treatment.
- Percutaneous radiofrequency ablation (RFA) has shown success in liver tumor treatment.
Purpose of the Study:
- To provide an overview of emerging therapies, including cyberknife surgery.
- To detail the indications, technique, and follow-up for RFA in lung tumors.
- To discuss complications, current results, and combination therapy potential of RFA.
Main Methods:
- Review of literature on thermal ablative therapies for lung tumors.
- Focus on percutaneous radiofrequency ablation (RFA) technique and indications.
- Discussion of follow-up strategies, potential complications, and outcomes.
Main Results:
- Radiofrequency ablation (RFA) is increasingly applied to primary and secondary lung tumors.
- The article highlights current results and potential complications associated with RFA.
- Combination therapy, including RFA with chemotherapy and radiation, is briefly addressed.
Conclusions:
- Radiofrequency ablation (RFA) is an expanding treatment option for lung tumors.
- Further research and clinical application are supported by growing publications.
- RFA shows promise as a potentially curative and minimally invasive therapeutic modality.
Related Concept Videos
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...